{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:17:59Z","timestamp":1791865079244,"version":"4.3.4"},"reference-count":60,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,6,17]]},"abstract":"<jats:p>Ceftolozane-tazobactam (C\/T) is a new fifth-generation cephalosporin\/beta-lactamase inhibitor combination approved by the Food and Drug Administration and the European Medicines Agency for treatment of complicated intraabdominal infections, complicated urinary tract infections, and hospital-acquired pneumonia in adult patients. This review will briefly describe the pharmacology of C\/T and focus on the emerging clinical trial and real-world data supporting its current utilization.<\/jats:p>","DOI":"10.1128\/aac.02318-20","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T10:38:28Z","timestamp":1618915108000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":44,"title":["New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam"],"prefix":"10.1128","volume":"65","author":[{"given":"Bryan D.","family":"Lizza","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Betthauser","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Ritchie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri, USA"},{"name":"Department of Pharmacy Practice, University of Health Sciences and Pharmacy, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Micek","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri, USA"},{"name":"Department of Pharmacy Practice, University of Health Sciences and Pharmacy, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0671-0751","authenticated-orcid":true,"given":"Marin H.","family":"Kollef","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2018.1447381"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2017.0266"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx468"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02461-20"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105883"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02431-18"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.02.004"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa278"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.05.13"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.04.017"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00875-17"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2018.11.021"},{"key":"e_1_3_2_14_2","volume-title":"Performance standards for antimicrobial susceptibility testing: 30th informational supplement.","author":"Clinical and Laboratory Standards Institute","year":"2020","unstructured":"Clinical and Laboratory Standards Institute. 2020. Performance standards for antimicrobial susceptibility testing: 30th informational supplement. CLSI document M100-S30. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_15_2","unstructured":"EUCAST. 2020. Breakpoint tables for interpretation of MICs and zone diameters version 10.0. http:\/\/www.eucast.org\/clinical_breakpoints\/."},{"key":"e_1_3_2_16_2","first-page":"215","article-title":"Ceftolozane\/tazobactam: a novel antipseudomonal cephalosporin and \u03b2-lactamase-inhibitor combination","volume":"5","author":"Hong MC","year":"2013","unstructured":"Hong MC, Hsu DI, Bounthavong M. 2013. Ceftolozane\/tazobactam: a novel antipseudomonal cephalosporin and \u03b2-lactamase-inhibitor combination. Infect Drug Resist 5:215\u2013223.","journal-title":"Infect Drug Resist"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx136"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1306"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx424"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix182"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9095203"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01637-19"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3361-0"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00675-18"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1609"},{"key":"e_1_3_2_26_2","unstructured":"Cubist Pharmaceuticals. 2014. Zerbaxa: full prescribing information. Cubist Pharmaceuticals Lexington MA. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/206829lbl.pdf."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01590-12"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03572-14"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01265-19"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-016-0143-9"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2018.11.005"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx221"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz416"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-018-1133-5"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu027"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106299"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks246"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.566"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa049"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62220-0"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ097"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30403-7"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01655-19"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1478"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/1559325819885790"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa014"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106158"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy790"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02291-19"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106270"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9100640"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy280"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz816"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10010079"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2017.37.2.174"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy801"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05519-y"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy723"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw353"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00160-19"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa139"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02318-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02318-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:13:05Z","timestamp":1645467185000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02318-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,6,17]]}},"alternative-id":["10.1128\/AAC.02318-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.02318-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"assertion":[{"value":"2021-06-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02318-20"}}